American Home Products
Executive Summary
Wyeth-Ayerst's "intentions [are] indefinite" with regard to marketing plans for cephalosporin cefpiramide, spokesperson said. Cefpiramide was approved by FDA Jan. 31 ("The Pink Sheet" March 27, p. 10). It is licensed by AHP from the Japanese firm Sumimoto.